Navigation Links
New Sub-Analysis of RE-LY Trial Examines Pradaxa in Patients with Atrial Fibrillation Undergoing Cardioversion
Date:1/5/2011

RIDGEFIELD, Conn., Jan. 5, 2011 /PRNewswire/ -- Results of a post-hoc analysis of the RE-LY® trial among patients with non-valvular atrial fibrillation (NVAF) undergoing cardioversion, a treatment to convert an abnormal heartbeat back to normal sinus rhythm, were published online on Jan. 3 in Circulation.(1)  Stroke and systemic embolism and major bleeding episodes within 30 days of the cardioversion were the major outcome measures.  The analysis reported that rates of stroke and systemic embolism and major bleeding were low and comparable to warfarin in cardioverted patients receiving Pradaxa® (dabigatran etexilate mesylate) 150mg capsules,(1) an oral anticoagulant recently approved by the U.S. Food and Drug Administration (FDA) to reduce the risk of stroke and systemic embolism in patients with NVAF.(2)

In RE-LY, a total of 1,983 cardioversions were performed in 1,270 patients, with similar numbers in each treatment group (647 in the dabigatran 110mg* group, 672 in the PRADAXA 150mg group and 664 in the warfarin group).(1)  Rates of stroke and systemic embolism within 30 days of cardioversion were low and did not differ significantly between treatment arms (0.77%, 0.3% and 0.6%, respectively; dabigatran 110mg vs. warfarin, p=0.71; PRADAXA 150mg vs. warfarin, p=0.45),(1) though the RE-LY trial and this subgroup analysis were not powered to demonstrate statistical significance.  Similarly, major bleeding within 30 days of cardioversion was infrequent and comparable between treatment groups (1.7%, 0.6% and 0.6%, respectively).(1)

"Cardioversion is one treatment option for patients with atrial fibrillation and requires anticoagulation both prior to and following treatment in order to reduce the risk of stroke," said Rangadham Nagarakanti, MD, Louisiana State University School of Medicine.  "It's helpful to know that patients on PRADAXA who underwent cardioversion had low rates of stroke and systemic embolism
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. New PLATO Sub-Analysis of CABG Patients Presented at ACC
2. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
3. Data Published in The Lancet Compare Dabigatran Etexilate to Dose-Adjusted Warfarin Across RE-LY® Trial Centers
4. New Analyses of Data From RE-LY Trial, Involving Oral Anticoagulant Pradaxa, to be Presented at American Heart Associations Scientific Sessions
5. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
6. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
7. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
8. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
9. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
10. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
11. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 28, 2015  For many medical institutions ... physicians and other inventors can be a constant challenge. ... difficult, and successes are rare. A new ... change that. Medical Device Investments (MDI) was ... universities, hospitals and physicians. MDI develops, manufactures and markets ...
(Date:7/28/2015)... 28, 2015 Transparency Market Research (TMR) ... " Cancer Diagnostics Market - Global Industry Analysis, Size, ... . According to this report, the global cancer diagnostics market ... the forecast period of 2014 to 2020. In 2013, the ... is expected to be worth US$168,649.3 million by 2020.The increasing ...
(Date:7/28/2015)... , July 28, 2015 The ... with the Canadian Anti-Fraud Centre (CAFC), ... falsely using the CIPA verification seal on illegitimate ... of legitimate online pharmacy member companies who have ... medications to more than 10 million Americans since ...
Breaking Medicine Technology:Medical Device Investments To Become Center Of Excellence For The Commercialization Of Innovative Medical Technologies 2Cancer Diagnostics Market is Expected to Grow at CAGR of 7.6% From 2014 to 2020, to be Worth US$168,649.3 Million by 2020: Transparency Market Research 2Cancer Diagnostics Market is Expected to Grow at CAGR of 7.6% From 2014 to 2020, to be Worth US$168,649.3 Million by 2020: Transparency Market Research 3Cancer Diagnostics Market is Expected to Grow at CAGR of 7.6% From 2014 to 2020, to be Worth US$168,649.3 Million by 2020: Transparency Market Research 4Canadian International Pharmacy Association (CIPA) Continues to Fight Rogues Fraudulently Using the Trusted CIPA Verification Seal 2Canadian International Pharmacy Association (CIPA) Continues to Fight Rogues Fraudulently Using the Trusted CIPA Verification Seal 3
... YORK, May 30, 2011 Reportlinker.com announces ... available in its catalogue: ... to 2015 http://www.reportlinker.com/p0535967/The-Global-Pharmaceutical-Fine-Chemicals-Market-Outlook-to-2015.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Chemical_and_Material ... This report provides a comprehensive overview ...
... 27, 2011 The U.S. Food and Drug Administration ... incontinence in patients for whom other therapies such as ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) Fecal ... can have different causes including nerve damage, weakened anal ...
Cached Medicine Technology:Reportlinker Adds The Global Pharmaceutical Fine Chemicals Market Outlook to 2015 2Reportlinker Adds The Global Pharmaceutical Fine Chemicals Market Outlook to 2015 3Reportlinker Adds The Global Pharmaceutical Fine Chemicals Market Outlook to 2015 4Reportlinker Adds The Global Pharmaceutical Fine Chemicals Market Outlook to 2015 5Reportlinker Adds The Global Pharmaceutical Fine Chemicals Market Outlook to 2015 6FDA Approves Injectable Gel to Treat Fecal Incontinence 2FDA Approves Injectable Gel to Treat Fecal Incontinence 3
(Date:7/28/2015)... ... July 28, 2015 , ... Mindful Her, a unique ... to take their healthy and mindful living practices to the next level, announced today ... of Living with Intent as keynote. Global Girls, an Orange County based non-profit ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... examines outcomes for inmates who continued methadone maintenance treatment (MMT) during incarceration versus ... likely to relapse to opiate use (1) and more likely to require hospitalization ...
(Date:7/28/2015)... ... July 28, 2015 , ... Darryl Worley’s ... volunteers celebrate the 14th year of raising money for the Darryl Worley Foundation. ... for this year’s main concert Saturday, Oct. 3. , This year’s concert will ...
(Date:7/28/2015)... ... ... By 2016, the number of smartphones worldwide will surpass 2 billion. This ... personal basis, increasing customer loyalty. However, capitalizing on this is not always obvious. Companies ... more nimble competitors. , The Open Mobile Summit 2015 is an influential gathering of ...
(Date:7/28/2015)... ... July 28, 2015 , ... Dr. Edward Buckingham and Buckingham Center ... in July 2016. Coming to Austin from Philadelphia, Dr. Roy will be completing ... long training is facilitated annually by the American Academy of Facial Plastic and Reconstructive ...
Breaking Medicine News(10 mins):Health News:Women’s Healthy Living Event Mindful Her Set for October 24, 2015 in Orange County 2Health News:Women’s Healthy Living Event Mindful Her Set for October 24, 2015 in Orange County 3Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 2Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 3Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 4Health News:Worley’s 14th Tennessee River Run Will Host Wade Hayes, Lorrie Morgan, Tracy Lawrence and Others 2Health News:Worley’s 14th Tennessee River Run Will Host Wade Hayes, Lorrie Morgan, Tracy Lawrence and Others 3Health News:Open Mobile Media: Etsy, Google, The Weather Company, CBS, TaskRabbit and New York Times: Moving from Web to Mobile-First 2Health News:Open Mobile Media: Etsy, Google, The Weather Company, CBS, TaskRabbit and New York Times: Moving from Web to Mobile-First 3Health News:Buckingham Center for Facial Plastic Surgery Welcomes Fellow 2Health News:Buckingham Center for Facial Plastic Surgery Welcomes Fellow 3
... Cambridge hope to revolutionise cancer therapy after discovering one of ... system to treat cancerous tumours have failed. New ... that a type of stromal cell found in many cancers ... role in suppressing the immune response in cancerous tumours ...
... University] In a major new study announced today ... biostatistian Constantine Gatsonis and his colleagues found that screening ... cancer deaths by 20 percent compared to using chest ... first definitive evidence for the effectiveness of helical CT ...
... could help smuggle drugs into the gut, according to ... Journal of Nanotechnology . There are several drugs ... could be targeted at absorption by the lower intestine. ... colon cancer for instance, medication delivered by mouth must ...
... (BRONX, NY) -- A team of scientists has found ... one of the main chemotherapy drugs used for treating colon ... in bacteria of the digestive tractcould allow patients to receive ... CPT-11 or Irinotecan. The study, spearheaded by scientists ...
... THURSDAY, Nov. 4 (HealthDay News) -- Variations in an immune ... to remain healthy without having to take any medications, scientists ... develop new HIV treatments and vaccines, the study authors pointed ... replication and keep viral load at extremely low levels in ...
... Behen HealthDay Reporter , THURSDAY, Nov. 4 (HealthDay ... may someday be able to boost your skills with the ... research suggests. In a study published in the Nov. ... Oxford University report that adults with normal math abilities were ...
Cached Medicine News:Health News:Breakthrough in cancer vaccine research 2Health News:Helical CT scans reduce lung cancer mortality by 20% compared to chest X-rays 2Health News:Helical CT scans reduce lung cancer mortality by 20% compared to chest X-rays 3Health News:Colonic navigation 2Health News:Discovery shows promise against severe side effects 2Health News:Protein Differences May Explain Long-Term HIV Control 2Health News:Electrical Brain Stimulation May Boost Math Skills 2Health News:Electrical Brain Stimulation May Boost Math Skills 3
... is Recognized as a Valuable Tool ... by Early Eye Disease. Near Test ... 7 in (12.7cm x 17.78cm) Can ... Refractor,Distance Test F.A.C.T. 201: Size ...
Pediatric: Binocular Balance, Tumbling "E" Monocular Acuity, Binocular Acuity, Fixation Disparity, Stereopsis...
Multi-Acuity: Letter Acuity, Tumbling E,and Allen Tests....
... Prostate specific antigen (PSA) is a serine ... within the epithelial cells of the,acini and ... or,serum is 0.1-2.6 ng/ml. Reports have suggested ... PSA is the must useful tumor,markers in ...
Medicine Products: